FDA Clearance Tracker · P250008
Claire OCT System
Last checked: Nov 20, 2026Latest source record: Mar 3, 2026 (this decision)Source: openFDAMethods & limitations
Decided
Mar 3, 2026
Approved
Time to decision
355 days
Received Mar 13, 2025. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA
Device class
Class III
The decision
- FDA number
- P250008
- Device name
- Claire OCT System
- Applicant
- Perimeter Medical Imaging Ai, Inc.
- Applicant location
- Toronto
- Received
- Mar 13, 2025
- Decided
- Mar 3, 2026
- Decision
- Approved
- Supplements
- 1 in FDA's data for this PMA. See them on the FDA record
Device type
- Device class
- Class III
FDA's approval statement
As written in FDA's record.
The Claire OCT System is an adjunctive three-dimensional imaging tool which provides volumetric cross-sectional, real-time depth visualization, coupled with an artificial intelligence computer-aided detection algorithm which identifies and marks focal areas suspicious for breast cancer and is used concurrently with physician interpretation of the images. The Claire OCT System is intended for use in conjunction with other standard methods for evaluation of the margins of excised lumpectomy tissue during surgical procedures in patients with a biopsy-confirmed diagnosis of breast cancer.
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- This is the earliest decision in FDA's data under product code SHH (OCT imaging system with AI/ML software for adjunctive detection of breast cancer).
- It is on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026).
Source documents
Other decisions for Perimeter Medical Imaging Ai, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K203578 · Decided Feb 25, 2021 · 80 days after receipt
Device type: System, Imaging, Optical Coherence Tomography (Oct) (NQQ) · Radiology & Imaging
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.